Specifically, augmented oxidative stress in T2DM patients leads to impairment in PINK1 and PARKIN-mediated mitophagy, as delineated by the reduced content of LC3II and LAMP2 proteins, resulting in aggregation of disturbed mitochondria. The gene discussed is LAMP2; the disease is type 2 diabetes mellitus.